Myelomonocytic leukemia
Study finds BM CH was present in nearly two-thirds of BPDCN patients and particularly prevalent in elderly patients.
The FDA and Finnish Medicines Agency cleared the investigational new drug application for bexmarilimab.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.